Alimera SciencesCompany Details

Get alertedif Alimera Sciences gets funded!
United States
Detailed industries:biotech
Company description

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.


Funding history

DateDeal sizeInvestors 
January 29th, 2014$37,500,000-View Deal
October 2nd, 2012$40,000,000-View Deal
May 25th, 2011$332,486-View Deal
September 2nd, 2009$5,000,000-View Deal
Create alert
Want to know when Alimera Sciences gets funded?
Key people
Philip AshmanSenior Vice President and European Managing Director
Susan CaballaExecutive_Officer, Sr. Vice President, Regulatory & Medical Affairs
Rick EiswirthCFO
Richard Eiswirth, JrCOO
Ken GreeneSr. Vice President & CSO
Dave Hollandsenior VP of sales and marketing
David HollandExecutive_Officer, senior VP of sales and marketing
Brian K. HalakBoard Member, Board of Directors
Garheng KongBoard of Directors
Dan MyersPresident and CEO
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!